Pilot study to investigate the feasibility of delayed vs immediate switching from efavirenz to etravirine in combination with NRTIs, and its effect on CNS toxicity in HIV-1-infected patients with persistent efavirenz-related CNS toxicity

Trial Profile

Pilot study to investigate the feasibility of delayed vs immediate switching from efavirenz to etravirine in combination with NRTIs, and its effect on CNS toxicity in HIV-1-infected patients with persistent efavirenz-related CNS toxicity

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Oct 2011

At a glance

  • Drugs Efavirenz; Emtricitabine/tenofovir disoproxil fumarate; Etravirine; Lamivudine/abacavir; Nucleoside reverse transcriptase inhibitors
  • Indications HIV infections
  • Focus Adverse reactions
  • Most Recent Events

    • 12 Oct 2011 Results presented at the 13th European AIDS Conference.
    • 19 Nov 2010 Results published in AIDS.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top